COMP <GO>
BMI vs RTX // 10Y YIELD & FRED MACRO BETA
Badger Meter Inc. (NYSE) VS. RTX Corporation (NYSE) • 15-METRIC TALLY: BMI 11
— RTX 3
▲ 10Y YIELD & FRED MACRO BETA LEADER: BMI
LAST: $148.38 (-0.87%) • MKT CAP: $4.28B
macro-sensitivity
1.14
LAST: $199.80 (+0.20%) • MKT CAP: $269.08B
macro-sensitivity
0.92
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BMI VS. RTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BMI | RTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.70% | 41.00% | +0.70 | BMI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.30% | 7.20% | +11.10 | BMI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 22.3x | 26.5x | -4.20 | BMI | /valuation <GO> |
| Free Cash Flow Yield | 3.97% | 2.95% | +1.02 | BMI | /fcf-yield <GO> |
| Operating Margin | 20.00% | 10.50% | +9.50 | BMI | /operating-margins <GO> |
| Net Profit Margin | 15.50% | 7.60% | +7.90 | BMI | /net-margins <GO> |
| Revenue Growth (YoY) | 10.90% | 9.70% | +1.20 | BMI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.02% | 1.33% | -0.31 | RTX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.42 | 2.73 | +5.69 | BMI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 9/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.60% | +0.80 | RTX | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.2 | 60.8 | +1.42 | BMI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.14 | 0.92 | +0.22 | BMI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.1x | 37.2x | -9.10 | BMI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.28B | $269.08B | -$264.80B | RTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BMI REV | RTX REV | BMI GROSS % | RTX GROSS % | BMI FCF | RTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $916.7M | $88.60B | 41.7% | 44.0% | $169.7M | $7.94B |
| FY 2024 | $826.6M | $80.74B | 39.8% | 44.0% | $142.2M | $4.53B |
| FY 2023 | $703.6M | $68.92B | 44.0% | 44.0% | $78.5M | $4.78B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BMI // BETA 1.14
RTX // BETA 0.92